“Destroy the tumor. Preserve the man.” 1 in 8 men will be diagnosed with prostate cancer during their lifetime. (1) The NanoKnife System is the only function-preserving therapy that uses electricity to destroy prostate tumors. Learn more: NanoKnife.com #NanoKnife

At the recent Cardiovascular Scientific Forum hosted by AngioDynamics, our SVP & GM of Cardiovascular & International, Laura Piccinini, delivered a powerful message to the attending physicians: We are listening. By engaging directly with the medical community, we reinforce our

The Solero Microwave Ablation System: Power, Precision, and Performance The Solero Microwave Ablation System is ready to meet the moment. The Solero technology is built for reliability, efficiency, and versatility across a broad range of soft tissue ablation procedures. We’re

The Solero System in Action: Simple. Speedy. Scalable. The Solero Microwave Ablation System isn’t just available—it’s delivering real results in clinical practice. With predictable ablation zones, an intuitive interface, and single applicator simplicity, the Solero Microwave

🏆 We’re proud to share that AngioDynamics has been named a 2025 MedTech Breakthrough Award winner in the “Best Overall Medical Device Company” category! This recognition celebrates our team’s relentless commitment to advancing patient care through innovative, clinically

What an incredible symposium – filled with thought-provoking discussions and inspiring connections. Thank you to all of you who stopped by and shared insights. Let’s keep the conversation going! For those who may have missed, learn more about our technology ▶️

#TeamAngio represented AngioDynamics at the 18th CDPHP Workforce Team Challenge the largest running event in the Capital District of New York! There were over 7,500 participants at this year's event in person and virtually representing nearly 450 local organizations. The

Thrilled to share we performed an aspiration thrombectomy in a 34yo male with IHR PE in normotensive shock 🫀🫁🔥Great result with AlphaVac F18 AngioDynamics, Inc. 🎯 On table improvement. FIRST patient worldwide enrolled in the RECOVER-AV study! 🚀

Congratulations to this year's President's Club inductees! Thank you for your dedication to AngioDynamics and showing your team what it means to WIN THE DAY. #AngioDynamics #teamangio #wintheday #employeerecognition #presidentsclub

We’re thrilled to announce the AngioDynamics Cardiovascular Scientific Forum! 📍 Phoenix, AZ 📅 October 10–12, 2025 💡 Innovation. Research. Collaboration. Use the following link to submit your interest for this event: angiodynamics.com/improving-care… US/NA/SM/3576 Rev. 01 06/2025

📖Featured: Endovascular Today📖 With the first patient enrollment, AMBITION BTK aims to generate critical evidence that could help redefine treatment standards for this complex patient population. evtoday.com/articles/2025-… US/PA/SM/3553 Rev 01 06/2025 auryon-system.com/risk-informati…

We believe progress starts with a conversation. We’re proud to host our second #CVSF, where thought leaders unite to advance patient care. 📍 Phoenix, AZ 📅 October 10–12, 2025 💡 Innovation. Research. Collaboration. Use this link to submit your interest: lnkd.in/ehyPPgef

The first patient has been successfully treated in the RECOVER-AV Study! Congratulations to olek.araszkiewicz & the team in Poznan, Poland! investors.angiodynamics.com/news-releases/… angiodynamics.com/about-us/risk-… The AlphaVac System is not available in all countries. Consult your AngioDynamics representative.

We are pleased to announce that AngioDynamics, Inc. has renewed their support of The PERT Consortium®, and our mission to establish, optimize, and expand multidisciplinary Pulmonary Embolism Response Teams (PERTs), and their quality care for pulmonary embolism (PE) patients. We thank

#CVSF2025 📍 Phoenix, AZ 📅 October 10–12, 2025 💡 Innovation. Research. Collaboration. Use the following link to submit your interest for an opportunity to attend our upcoming event: lnkd.in/ehyPPgef #CardiovascularCare #AngioDynamics #AlwaysListening #Innovation

Registration Now Open! #CVSF2025 📍 Phoenix, AZ 📅 October 10–12, 2025 💡 Innovation. Research. Collaboration. Contact your local AngioDynamics representative for more details or, use the following link to submit your interest for consideration: lnkd.in/ehyPPgef

Are you ready to share your bold ideas, cutting-edge research, and clinical innovation in #cardiovascularcare? The Cardiovascular Pitch is your chance to make a high-impact impression! 📅 Deadline: Sept. 15, 2025 ▶️ angiodynamics.com/improving-care… #CVSF2025 #AngioDynamics #MedTech

Congratulations to Dr. Anahita Dua MD MS MBA FACS and the team at MassGeneral News on successfully enrolling the first patient in the #AMBITIONBTK multicenter randomized controlled trial. ▶️ investors.angiodynamics.com/news-releases/… auryon-system.com/risk-informati…

Mark your calendars for CVSF – Where Innovation Meets Education! Agenda Highlights include: 🔹 Keynote address & expert panels 🔹 Breakout/Hands-on sessions offering CME credits* 🔹 Hands-on Cardiovascular Lab 🔹 Networking receptions & awards Stay tuned for more details!

Due to high demand, registration for #CVSF2025 has reached full capacity. Don’t miss the opportunity to attend the next CVSF, taking place in February 2026, Fort Lauderdale, FL! Submit your interest for CVSF 2026: bit.ly/3H957N5